is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 (COVID‑19).
Pfizer stock fell 0.9% in premarket trading on Tuesday after the pharma giant said Paxlovid, its antiviral drug for treating COVID-19, will generate less...
SK bioscienceSK bioscience and GSK announced submission of a biologics license application for SKYCovione™ a recombinant protein-based COVID-19 vaccine candidate adjuvanted with GSK’s pandemic...
Africa's first COVID-19 vaccination plant, touted last year as a trailblazer for an under-vaccinated continent frustrated by sluggish Western handouts, risks shutting down after...
Shares in the small-cap biotech jumped 37.5% to 9.9 cents each after reporting positive COVID-19 animal trial results today.
Biotron Limited is engaged in the...
AstraZeneca PLC said Friday that it expects sales of total revenue from COVID-19 medicines is anticipated to decline by a low-to-mid twenties percentage, but...
New research has shown that a longer interval between primary COVID-19 vaccine doses can boost antibody production up to nine-fold. The study currently being presented at...